We observed nucleocytoplasmic shuttling of pSTAT3 in the presence of imatinib in CML cells and found that nuclear accumulation of activated STAT3 (pSTAT3) was greater in KLC2-MT cells than in KLC2-WT cells. This evidence concerns the gene KLC2 and chronic myelogenous leukemia, BCR-ABL1 positive.